Vycor Medical (VYCO) Change in Account Payables (2010 - 2026)
Vycor Medical (VYCO) reported Change in Account Payables of $5712.0 for Q1 2026, down 67.51% year-over-year from $17582.0 in Q1 2025, and down 93.66% quarter-over-quarter from $90032.0 in Q4 2025.
Vycor Medical (VYCO) Change in Account Payables (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Change in Account Payables data on file, last reported at $5712.0 in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $5712.0, down 67.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $23414.0 (up 14.64% YoY), and the FY2025 annual result was $35284.0, up 137.24% from the prior year.
- Change in Account Payables retreated to $5712.0 in Q1 2026 per VYCO's latest filing, from $90032.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $108411.0 in Q3 2022 and troughed at -$79890.0 in Q3 2025.
- A 5-year average of $8034.4 and a median of $12031.0 in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables soared 1240.39% in 2022, then sank 735.51% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $11306.0 in 2022, then slumped by 63.98% to $4072.0 in 2023, then slumped by 654.27% to -$22570.0 in 2024, then soared by 498.9% to $90032.0 in 2025, then sank by 93.66% to $5712.0 in 2026.
- Business Quant data shows VYCO's Change in Account Payables at $5712.0 in Q1 2026, $90032.0 in Q4 2025, and -$79890.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 | 5,712.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,712.00 |
| Mar 31, 2026 | 5,712.00 |
| Dec 31, 2025 | 90,032.00 |
| Dec 31, 2025 | 90,032.00 |
| Sep 30, 2025 | -79,890.00 |
| Sep 30, 2025 | -79,890.00 |
| Jun 30, 2025 | 7,560.00 |
| Jun 30, 2025 | 7,560.00 |
| Mar 31, 2025 | 17,582.00 |
| Mar 31, 2025 | 17,582.00 |
| Dec 31, 2024 | -22,570.00 |
| Dec 31, 2024 | -22,570.00 |
| Sep 30, 2024 | 12,571.00 |
| Sep 30, 2024 | 12,571.00 |
| Jun 30, 2024 | 12,841.00 |
| Jun 30, 2024 | 12,841.00 |
| Mar 31, 2024 | 12,031.00 |
| Mar 31, 2024 | 12,031.00 |
| Dec 31, 2023 | 4,072.00 |
| Dec 31, 2023 | 4,072.00 |